Strength
2 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762100301
Classification
Generic
Dosage Form
TABLET, SUGAR COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
SIROLIMUSApproval Type
Authorized Generic (NDA)
FDA Application
NDA021110On Market Since
10/27/2014
Pharmacological Classes
Decreased Immunologic Activity
Kinase Inhibitor
Protein Kinase Inhibitors
mTOR Inhibitor Immunosuppressant
mTOR Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
IMATINIB MESYLATE 100 MG TAB
Generic
72485020290•Armas Pharmaceuticals Inc.
$0.4912
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
00093762998•Teva Pharmaceuticals USA Inc.
$0.7940
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
00378224577•Mylan Pharmaceuticals Inc.
$0.7940
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
00832053209•Upsher-Smith Laboratories LLC
$0.7940
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
00904690104•Major Pharmaceuticals
$0.7940
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
31722029690•Camber Pharmaceuticals Inc.
$0.7940
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
42292004303•Mylan Institutional LLC
$0.7940
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
43598034431•Dr. Reddy's Laboratories Inc.
$0.7940
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
47335047281•Sun Pharmaceutical Industries Inc.
$0.7940
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
59651024090•Aurobindo Pharma Limited
$0.7940
per EA